Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HTR3A | P46098 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.95 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.95 |
| ▸ | APEX1 | P27695 | 3/20 | 0.95 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.95 |
| ▸ | BLM | P54132 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | RECQL | P46063 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.59 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octopamine SCHEMBL3489184 | 1.00 | TAAR1 (1.00) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL22605 | 1.00 | TAAR1 (1.00) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL4282037 | 0.98 | TAAR1 (0.95) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL30782000 | 0.98 | TDP1 (1.00) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL17688531 | 0.98 | TAAR1 (0.95) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL1168914 | 0.98 | TDP1 (1.00) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL5458985 | 0.98 | TAAR1 (0.95) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL9125963 | 0.95 | TAAR1 (0.91) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL8419660 | 0.91 | TAAR1 (0.83) | TAAR1HIF1ANFKB1TSHRHTR3A | |
| Octopamine SCHEMBL25250966 | 0.89 | TAAR1 (0.80) | TAAR1HIF1ANFKB1TSHRHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112822948-A | TAAR receptor agonists for the treatment of alopecia | 应用生物学公司 | 2021-05-18 | — | — | CN | claimed |
| US-20210137854-A1 | TAAR Receptor Agonists for the Treatment of Alopecia | JUPITER WELLNESS INC. | 2021-05-13 | — | — | US | claimed |
| US-20100143322-A1 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | PLT PATENT & LICENCE TRADING LTD., C/O THE B-NET (GB) | 2010-06-10 | — | — | US | claimed |
| EP-1917006-A2 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | PLT Patent & Licence Trading Ltd. (GB) | 2008-05-07 | — | — | EP | claimed |
| WO-2006136454-A2 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | PLT PATENT & LICENCE TRADING LTD. (GB) | 2006-12-28 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| US-5747462-A | PLANT EXTRACT OF CACTACEAE CONTAINING AMINOETHYLPHENOLS, A DISACCHARIDE AND A MONSACCHARIDE | LABORATORIO CHILE S.A. (CL) | 1998-05-05 | — | — | US | claimed |
| CN-1127116-A | New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec | CHILE LAB SA (CL) | 1996-07-24 | — | — | CN | claimed |
| EP-0706797-A2 | Compositions containing carbohydrates obtained from plants of the family cactacea | LABORATORIO CHILE S.A. (CL) | 1996-04-17 | — | — | EP | claimed |
| US-20260041652-A1 | SYSTEM AND METHOD FOR PREVENTING ALOPECIA | FOLLEA INT (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| WO-2025059259-A1 | NEW PROCESS FOR PHENYLEPHRINE AND SALBUTAMOL AND RELATED COMPOUNDS VIA ASYMETRIC TRANSFER HYDROGENATION OF UNPROTECTED AMINO KETONES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2025-03-20 | — | — | WO | disclosed |
| CN-115993416-B | Method for detecting biogenic amine in fermentation product | 浙江省疾病预防控制中心 | 2024-11-19 | — | — | CN | disclosed |
| CN-117756947-B | High-throughput screening method for recombinant engineering protein and proteasome inhibitor | 中南大学湘雅二医院 | 2024-09-06 | — | — | CN | disclosed |
| US-5128369-A | Antiallergens, bronchodilator agents | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5120746-A | Inhibit gastric acid secretion | TOYAMA CHEMICAL CO., LTD. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0404197-A2 | Arylalkylamine derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-12-27 | — | — | EP | disclosed |
| US-4923882-A | Novel amine derivatives, salts thereof and an anti-ulcer agent containing the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-05-08 | — | — | US | disclosed |
| CN-87103323-A | The method for preparing new Dopamine HCL, hydroxylase inhibitors | — | 1988-02-03 | — | — | CN | disclosed |
| US-4643849-A | ANTIULCER, ANTISECRETORY AGENTS | TOYAMA CHEMICAL CO., LTD. (JP) | 1987-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041652-A1 | SYSTEM AND METHOD FOR PREVENTING ALOPECIA | DYRK4, DYRK2, STRA6 | TAAR1 370/4885HIF1A 3522/4885NFKB1 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.